2005P-0411 | Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs | |||||||||||||||||||||||
FDA Comment Number : | EC7540 | |||||||||||||||||||||||
Submitter : | Mrs. Norma Stryzewski | Date & Time: | 03/06/2006 04:03:50 | |||||||||||||||||||||
Organization : | Mrs. Norma Stryzewski | |||||||||||||||||||||||
Category : | Drug Association | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
I have used 'compounded' Bio-identical hormone prescriptions for almost 8 years and have not suffered any of the effects of menopause that many friends and clients have. I am concerned that Wyeth's petition (Docket #2005P-o411) would limit the ability of good physicians and pharmacists to keep prescribing these for me and my peers. The FDA needs to reject Wyeth's petition and pay more attention to the labeling of saturated and trans fats in food products. | ||||||||||||||||||||||||